Clinical study of avmacol for detoxification of tobacco carcinogens in heavy smokers

Ended Awarded Last action

Contract number
HHSN26100012
Awardee
Awarding agency
Obligated
$796,585

Award facts

Opportunity
  • N01CN0501469 Solicitation number
Contract value 100% obligated
$796,585.45 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 7 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Tucson, AZ 85719, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00005 -$5,354
Change Order P00004 $0
Exercise an Option P00003 $44,794
Change Order P00002 $0
Exercise an Option P00001 $269,250
Original award $487,895

About this award

This is a federal contract award to the University of Arizona, doing business as the Arizona Board of Regents, by the National Cancer Institute (NCI). The $796,585.45 contract is for a clinical study of Avmacol, a product aimed at detoxifying tobacco carcinogens in heavy smokers. This award is part of the NCI's Cancer Prevention Agent Development Program, which funds early-phase clinical research. The contract is a delivery order under a master Indefinite Delivery/Indefinite Quantity (IDIQ) contract for this program, and has no set-aside designation. The University of Arizona has extensive experience conducting federal research and providing specialized scientific services to agencies like the Department of Veterans Affairs and NASA through contracts and grants. As a public research university and land grant institution, the university leverages its broad capabilities to support federal missions across diverse domains.

Quick answers

Who was awarded contract HHSN26100012?

HHSN26100012 was awarded to University Of Arizona by National Cancer Institute (National Institutes of Health) on September 15, 2017.

How much is contract HHSN26100012 worth?

The government has obligated $796,585 on HHSN26100012.

Is contract HHSN26100012 an order under another contract?

Yes. HHSN26100012 is a delivery order under HHSN261201200031I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.

Was contract HHSN26100012 competed?

The extent of competition for HHSN26100012 was full and open competition. The government received 7 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award